Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6071.0000 61.00 (1.01%)
NSE Jan 22, 2026 15:31 PM
Volume: 372.2K
 

6071.00
1.01%
Karvy
Revenues and margins outperform: Divis Labs Net revenues increased by 44.4% YoY to Rs 12.9 bn, which ishigher than our estimates of Rs 10.2 bn for the quarter. The Operatingmargins were at 40% in Q2FY19 (much higher than our estimate of 34.7%) asagainst 31% in Q2FY18 on account of better gross margin and lowerexpenditure.
Divi's Laboratories Ltd. is trading below all available SMAs
More from Divi's Laboratories Ltd.
Recommended